We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+27.94%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.4B
AUM Growth
+$6.4B
Cap. Flow
-$900M
Cap. Flow %
-2.23%
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259

Top Buys

Rank Stock Value
1
IBM icon
IBM
IBM
+$245M
2
BMY icon
Bristol-Myers Squibb
BMY
+$143M
3
MMM icon
3M
MMM
+$142M
4
PEG icon
Public Service Enterprise Group
PEG
+$108M
5
KEY icon
KeyCorp
KEY
+$80.9M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$378M
2
KMB icon
Kimberly-Clark
KMB
+$186M
3
MO icon
Altria Group
MO
+$141M
4
ABBV icon
AbbVie
ABBV
+$141M
5
PFE icon
Pfizer
PFE
+$120M

Sector Composition

Rank Sector Weight
1 Healthcare 22.35%
2 Technology 19%
3 Consumer Discretionary 10.55%
4 Financials 9.89%
5 Communication Services 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LUMO
2101
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$2K ﹤0.01%
113
+11
+11% +$131
HMNF
2102
DELISTED
HMN Financial Inc
HMNF
$2K ﹤0.01%
147
-15
-9% -$228
LL
2103
DELISTED
LL Flooring Holdings, Inc.
LL
$2K ﹤0.01%
+114
New +$967
CBAY
2104
DELISTED
Cymabay Therapeutics
CBAY
$2K ﹤0.01%
517
-124,522
-100% -$359K
RVLP
2105
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$2K ﹤0.01%
223
-330
-60% -$1.61K
RAD
2106
DELISTED
Rite Aid Corporation
RAD
$2K ﹤0.01%
112
-2,795
-96% -$37.7K
PRVB
2107
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$2K ﹤0.01%
+124
New +$1.57K
OPNT
2108
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$2K ﹤0.01%
+248
New +$2.57K
SPNE
2109
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$2K ﹤0.01%
213
-360
-63% -$3.68K
NH
2110
DELISTED
NantHealth, Inc
NH
$2K ﹤0.01%
+24
New +$957
VOLT
2111
DELISTED
Volt Information Sciences, Inc.
VOLT
$2K ﹤0.01%
+1,622
New +$1.51K
ARNA
2112
DELISTED
Arena Pharmaceuticals Inc
ARNA
$2K ﹤0.01%
29
-118,763
-100% -$6.53M
CHMA
2113
DELISTED
Chiasma, Inc. Common Stock
CHMA
$2K ﹤0.01%
380
-11
-3% -$61
AT
2114
DELISTED
Atlantic Power Corporation
AT
$2K ﹤0.01%
+900
New +$1.79K
NTRP
2115
DELISTED
Neurotrope, Inc. Common
NTRP
$2K ﹤0.01%
+1,464
New +$1.83K
ABEO icon
2116
Abeona Therapeutics
ABEO
$313M
$1K ﹤0.01%
+17
New +$1.18K
AGX icon
2117
Argan
AGX
$5.45B
$1K ﹤0.01%
2
AGYS icon
2118
Agilysys
AGYS
$2.95B
$1K ﹤0.01%
44
-242
-85% -$4.54K
AMS icon
2119
American Shared Hospital Services
AMS
$9.44M
$1K ﹤0.01%
587
ATRC icon
2120
AtriCure
ATRC
$2.86B
$1K ﹤0.01%
23
+20
+667% +$871
AVTX icon
2121
Avalo Therapeutics
AVTX
$862M
0
BBSI icon
2122
Barrett Business Services
BBSI
$820M
$1K ﹤0.01%
8
-152
-95% -$1.76K
BGFV
2123
DELISTED
Big 5 Sporting Goods
BGFV
$1K ﹤0.01%
128
-133
-51% -$200
BRC icon
2124
Brady Corp
BRC
$4B
$1K ﹤0.01%
17
CAL icon
2125
Caleres
CAL
$425M
$1K ﹤0.01%
+176
New +$1.23K

Similar funds

Federated Hermes's Q2 2020 Portfolio in Review

As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
  • Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
  • Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
  • Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
  • Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
  • Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
  • Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.

Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.